首页 | 本学科首页   官方微博 | 高级检索  
     


Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk‐adapted adjuvant therapy for squamous cell carcinoma of the head and neck
Authors:Jared M. Weiss MD  Juneko E. Grilley‐Olson MD  Allison Mary Deal MS  Jose P. Zevallos MD  Bhishamjit S. Chera MD  Jennifer Paul PA‐C  Mary Fleming Knowles NP  Dmitriy Usenko MD  Mark C. Weissler MD  Samip Patel MD  David N. Hayes MD  MPH  Trevor Hackman MD
Affiliation:1. Department of Hematology and Oncology, Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, North Carolina;2. Lineberger Cancer Center at the University of North Carolina, Chapel Hill, North Carolina;3. Head and Neck Surgical Oncology, Washington University School of Medicine, St Louis, Missouri;4. Department of Radiation Oncology, Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, North Carolina;5. Division of Head and Neck Surgery, Department of Otolaryngology, Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, North Carolina;6. West Cancer Center, Germantown, Tennessee
Abstract:
Keywords:induction chemotherapy  lapatinib  neoadjuvant  squamous cell carcinoma of the head and neck  transoral surgery
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号